Literature DB >> 21849561

Dual regulation of anterograde and retrograde transmission by endocannabinoids.

Karl J Iremonger1, J Brent Kuzmiski, Dinara V Baimoukhametova, Jaideep S Bains.   

Abstract

Endocannabinoids (eCBs) are feedback messengers in the nervous system that act at the presynaptic nerve terminal to inhibit transmitter release. Here we report that in brain slices from rat, eCBs are released from vasopressin (VP) neurons in the paraventricular nucleus of the hypothalamus following coincident bursts of presynaptic and postsynaptic spiking. eCBs transiently depress glutamate release from excitatory terminals and, in doing so, prevent the synapses from undergoing long-term depression (LTD). Specifically, we show that blockade of CB1 receptors unmasks LTD following coincident presynaptic and postsynaptic activity. This LTD is presynaptic in nature, but requires the release of the opioid peptide dynorphin from the postsynaptic neuron. Dynorphin release and subsequent LTD require the activation of postsynaptic metabotropic glutamate receptors (mGluRs). Our findings indicate that eCBs, by transiently depressing glutamate release, limit mGluR activation and indirectly gate release of dynorphin from the postsynaptic neuron. We propose that eCBs, in addition to their well described role in the rapid modulation of transmitter release from the nerve terminal, also regulate the release of other retrograde transmitters and thus encode for multiple temporal windows of synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849561      PMCID: PMC6623194          DOI: 10.1523/JNEUROSCI.2925-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  11 in total

Review 1.  Neuropeptide modulation of microcircuits.

Authors:  Michael P Nusbaum; Dawn M Blitz
Journal:  Curr Opin Neurobiol       Date:  2012-02-01       Impact factor: 6.627

2.  Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum.

Authors:  Brady K Atwood; David A Kupferschmidt; David M Lovinger
Journal:  Nat Neurosci       Date:  2014-02-23       Impact factor: 24.884

3.  Opioids potentiate electrical transmission at mixed synapses on the Mauthner cell.

Authors:  Roger Cachope; Alberto E Pereda
Journal:  J Neurophysiol       Date:  2015-05-27       Impact factor: 2.714

Review 4.  Functional consequences of neuropeptide and small-molecule co-transmission.

Authors:  Michael P Nusbaum; Dawn M Blitz; Eve Marder
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

Review 5.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

Review 6.  Presynaptic long-term depression mediated by Gi/o-coupled receptors.

Authors:  Brady K Atwood; David M Lovinger; Brian N Mathur
Journal:  Trends Neurosci       Date:  2014-08-24       Impact factor: 13.837

7.  Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex.

Authors:  Leonora E Long; Jonna Lind; Maree Webster; Cynthia Shannon Weickert
Journal:  BMC Neurosci       Date:  2012-07-24       Impact factor: 3.288

Review 8.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

9.  Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses.

Authors:  Jaclyn I Wamsteeker Cusulin; Tamás Füzesi; Wataru Inoue; Jaideep S Bains
Journal:  Nat Neurosci       Date:  2013-04-07       Impact factor: 24.884

10.  High-frequency stimulation-induced peptide release synchronizes arcuate kisspeptin neurons and excites GnRH neurons.

Authors:  Jian Qiu; Casey C Nestor; Chunguang Zhang; Stephanie L Padilla; Richard D Palmiter; Martin J Kelly; Oline K Rønnekleiv
Journal:  Elife       Date:  2016-08-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.